ADVM250919C00007000 Option on Adverum Biotechnologies

An 'Out of The Money' option on Adverum has a strike price that Adverum Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Adverum Biotechnologies' 'Out of The Money' options include buying the options if you expect a big move in Adverum Biotechnologies' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

Adverum Biotechnologies' Option Greeks for the contract ending on 2025-09-19 at a strike price of 7.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Adverum Biotechnologies' option greeks, its implied volatility helps estimate the risk of Adverum Biotechnologies stock implied by the prices of the options on Adverum Biotechnologies' stock.

Put options written on Adverum Biotechnologies grant holders of the option the right to sell a specified amount of Adverum Biotechnologies at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Adverum Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Adverum Biotechnologies is like buying insurance aginst Adverum Biotechnologies' downside shift.

By selling Adverum Biotechnologies' put option, the investors signal their bearish sentiment. A short position in a put option written on Adverum Biotechnologies will generally make money when the underlying price is above the strike price. Therefore Adverum Biotechnologies' put payoff at expiration depends on where the Adverum Stock price is relative to the put option strike price. The breakeven price of 7.15 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Adverum Biotechnologies' price. Finally, at the strike price of 7.0, the payoff chart is constant and positive.

Adverum Biotechnologies' option chain is a display of a range of information that helps investors for ways to trade options on Adverum. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Adverum. It also shows strike prices and maturity days for a Adverum Biotechnologies against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.